Bristol-Myers Squibb buy Barclays PLC
Start price
21.02.26
/
50%
€50.83
Target price
21.02.27
€63.65
Performance (%)
7.55%
Price
22:25
€55.02
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 7.55%. This prediction currently runs until 21.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 2.862% | 2.862% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by Barclays_PLC for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $75.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Barclays_PLC for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€48.85
07.10.24
07.10.24
€39.19
07.10.25
07.10.25
-20.99%
08.10.25
08.10.25
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€42.92
22.08.24
22.08.24
€37.80
22.08.25
22.08.25
-4.19%
23.08.25
23.08.25